1. Home >
  2. M&A >
  3. Growth Capital >
  4. United States >
  5. New York >
  6. Mountaingate Capital Invests In Anteriad

Investment Summary

Mountaingate Capital Invests In Anteriad

On May 29, 2019, growth capital firm Mountaingate Capital invested in marketing company Anteriad

Investment Highlights
  • This is Mountaingate Capital’s 1st transaction in the Marketing sector.
  • This is Mountaingate Capital’s 7th transaction in the United States.
  • This is Mountaingate Capital’s 2nd transaction in New York.

Investment Summary
Date 2019-05-29
Target Anteriad
Sector Marketing
Investor(s) Mountaingate Capital
Deal Type Growth Capital

Target

Anteriad

Rye Brook, New York, United States
Anteriad is a provider of multi-channel B2B database products and service solutions. Anteriad leverages its major database technology platform to give multi-channel marketers access to the most comprehensive, current, and relevant B2B data in the market so they can optimize and improve their customer acquisition and retention efforts. Anteriad was founded in 2000 and is based in Rye Brook, New York.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Mountaingate Capital

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2016
PE ASSETS 1.4B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Mountaingate Capital is a private equity firm focused on acquiring middle-market companies with $5 to $25 million of EBITDA. The Firm focuses on growth-oriented companies in the business services, specialty manufacturing, marketing, and distribution sectors. Mountaingate looks to partner with management when investing and will consider transaction situations from buyouts, to consolidations and recapitalizations. Mountaingate Capital was formed in 2016 and is based in Denver, Colorado.

DEAL STATS #
Overall 7 of 19
Sector: Marketing M&A 1 of 7
Type: Growth Capital M&A Deals 3 of 14
State: New York M&A 2 of 2
Country: United States M&A 7 of 18
Year: 2019 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-29 Real Chemistry

New York, New York, United States

Real Chemistry is a global health company, focused on delivering analytics-driven, digital-first solutions to the healthcare industry. Real Chemistry uses proprietary technology, healthcare-specific data analytics and deep subject matter expertise to enable its clients to efficiently engage with the broader healthcare ecosystem – including consumers, providers, physicians and payors – and address complex commercial challenges, such as physician education, clinical trial engagement, consumer disease awareness, patient engagement, brand positioning and value articulation. Real Chemistry was founded in 2001 and is based in New York, New York.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-07-10 Revunit

Bentonville, Arkansas, United States

RevUnit is a digital strategy and product studio helping enterprise workforces leverage technology to work better. RevUnit was formed in 2012 and is based in Bentonville, Arkansas.

Buy -
Mergr

Solution for

Product

Company

Legal